| Identification | Back Directory | [Name]
cedrelone | [CAS]
1254-85-9 | [Synonyms]
AC1MJ135
cedrelone
(13α,17α)-14β,15β:21,23-Diepoxy-6-hydroxy-4,4,8-trimethyl-24-norchola-1,5,20,22-tetrene-3,7-dione
24-Norchola-1,5,20,22-tetraene-3,7-dione,14,15:21,23-diepoxy-6-hydroxy-4,4,8-trimethyl-, (13a,14b,15b,17a)-
24-Norchola-1,5,20,22-tetraene-3,7-dione, 14,15:21,23-diepoxy-6-hydroxy-4,4,8-trimethyl-, (13α,14β,15β,17α)-
(1S,2aR,3aR,3bR,9aR,9bR,11aS)-1-(furan-3-yl)-5-hydroxy-3b,6,6,9a,11a-pentamethyl-2,2a,6,9a,9b,10,11,11a-octahydronaphtho[1',2':6,7]indeno[1,7a-b]oxirene-4,7(1H,3bH)-dione | [Molecular Formula]
C26H30O5 | [MDL Number]
MFCD20260694 | [MOL File]
1254-85-9.mol | [Molecular Weight]
422.52 |
| Hazard Information | Back Directory | [Uses]
Cedrelone, a limonoid, is a Phenazine biosynthesis-like domain-containing protein (PBLD) activator. Cedrelone induces cancer cell apoptosis, and possess antitumor effects[1]. | [References]
[1] Jiansong Wu, et al. Novel compound cedrelone inhibits hepatocellular carcinoma progression via PBLD and Ras/Rap1. Exp Ther Med. 2019 Dec;18(6):4209-4220. DOI:10.3892/etm.2019.8080 |
|
| Company Name: |
BioBioPha Co., Ltd.
|
| Tel: |
0871-65217109 13211707573; |
| Website: |
http://www.biobiopha.com |
|